Hinova Pharmaceuticals (SH:688302) Xin Lang Cai Jing·2025-10-31 02:13Group 1 - HaiChuang Pharmaceutical (688302.SH) reported its Q3 2025 results on October 31, 2025, with 11 institutional investors holding a total of 34.54% of the company's shares, amounting to 34.2005 million shares [1] - The top ten institutional investors collectively hold 34.42% of the shares, with a decrease of 2.15 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, Penghua Innovation Growth One-Year Holding Mixed A, reported a slight decrease in holdings compared to the previous quarter [2] - A total of 78 public funds did not disclose their holdings this quarter, including notable funds such as Yinhua Digital Economy Stock Initiation A and CITIC Construction Investment Medical Reform A [2]